Novartis Research Foundation's FMI Director Susan Gasser: An Interview With "The Pink Sheet" DAILY (Part 1 Of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
The Director of the Friedrich Miescher Institute for Biomedical Research talks about discovery research, collaborating with Novartis and big pharma's interest in treating orphan diseases.
You may also be interested in...
Novartis Research Foundation's FMI Director Susan Gasser: An Interview With "The Pink Sheet" DAILY (Part 2 Of 2)
The Director of the Friedrich Miescher Institute for Biomedical Research talks about the orphan drug space, and big pharma's growing interest in it.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.